These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 1554170)
1. Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia. McCabe JL; Adhar GC; Menegazzi JJ; Paris PM Ann Emerg Med; 1992 Apr; 21(4):358-61. PubMed ID: 1554170 [TBL] [Abstract][Full Text] [Related]
2. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Gausche M; Persse DE; Sugarman T; Shea SR; Palmer GL; Lewis RJ; Brueske PJ; Mahadevan S; Melio FR; Kuwate JH Ann Emerg Med; 1994 Aug; 24(2):183-9. PubMed ID: 8037382 [TBL] [Abstract][Full Text] [Related]
3. Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control. Furlong R; Gerhardt RT; Farber P; Schrank K; Willig R; Pittaluga J Am J Emerg Med; 1995 Jul; 13(4):383-8. PubMed ID: 7605518 [TBL] [Abstract][Full Text] [Related]
4. Conversion rates for prehospital paroxysmal supraventricular tachycardia (PSVT) with the addition of adenosine: a before-and-after trial. Morrison LJ; Allan R; Vermeulen M; Dong SL; McCallum AL Prehosp Emerg Care; 2001; 5(4):353-9. PubMed ID: 11642584 [TBL] [Abstract][Full Text] [Related]
5. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Cairns CB; Niemann JT Ann Emerg Med; 1991 Jul; 20(7):717-21. PubMed ID: 2064090 [TBL] [Abstract][Full Text] [Related]
6. Adenosine for the treatment of PSVT in the prehospital arena: efficacy of an initial 6 mg dosing regimen. Wittwer LK; Muhr MD Prehosp Disaster Med; 1997; 12(3):237-9. PubMed ID: 10187020 [TBL] [Abstract][Full Text] [Related]
7. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting. Madsen CD; Pointer JE; Lynch TG Ann Emerg Med; 1995 May; 25(5):649-55. PubMed ID: 7741343 [TBL] [Abstract][Full Text] [Related]
8. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560 [TBL] [Abstract][Full Text] [Related]
9. Successful conversion of unstable supraventricular tachycardia to sinus rhythm with adenosine. Melio FR; Mallon WK; Newton E Ann Emerg Med; 1993 Apr; 22(4):709-13. PubMed ID: 8457100 [TBL] [Abstract][Full Text] [Related]
10. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist. Prystowsky EN; Niazi I; Curtis AB; Wilber DJ; Bahnson T; Ellenbogen K; Dhala A; Bloomfield DM; Gold M; Kadish A; Fogel RI; Gonzalez MD; Belardinelli L; Shreeniwas R; Wolff AA J Am Coll Cardiol; 2003 Sep; 42(6):1098-102. PubMed ID: 13678937 [TBL] [Abstract][Full Text] [Related]
11. High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia. Cheng L; Eilbert W Am J Emerg Med; 2020 Jul; 38(7):1541.e3-1541.e4. PubMed ID: 32278568 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population. Seet CM Singapore Med J; 1997 Dec; 38(12):525-8. PubMed ID: 9550919 [TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings. Ip JE; Bui H; Camm AJ; Coutu B; Noseworthy PA; Parody ML; Sears SF; Singh N; Uribe JA; Vyselaar J; Omodele S; Shardonofsky S; Bharucha DB; Stambler B Am Heart J; 2024 Apr; 270():55-61. PubMed ID: 38266665 [TBL] [Abstract][Full Text] [Related]
14. Treatment of paroxysmal supraventricular tachycardia with adenosine: implications for nursing. Severson AL; Meyer LT Heart Lung; 1992; 21(4):350-6. PubMed ID: 1629004 [TBL] [Abstract][Full Text] [Related]
15. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia. Parker RB; McCollam PL Clin Pharm; 1990 Apr; 9(4):261-71. PubMed ID: 2184971 [TBL] [Abstract][Full Text] [Related]
16. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. Ballo P; Bernabò D; Faraguti SA Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158 [TBL] [Abstract][Full Text] [Related]
17. Adenosine-induced atrial arrhythmia: a prospective analysis. Strickberger SA; Man KC; Daoud EG; Goyal R; Brinkman K; Knight BP; Weiss R; Bahu M; Morady F Ann Intern Med; 1997 Sep; 127(6):417-22. PubMed ID: 9312997 [TBL] [Abstract][Full Text] [Related]
18. Comparing methods of adenosine administration in paroxysmal supraventricular tachycardia: a pilot randomized controlled trial. Daengbubpha P; Wittayachamnankul B; Sutham K; Chenthanakij B; Tangsuwanaruk T BMC Cardiovasc Disord; 2022 Jan; 22(1):15. PubMed ID: 35081915 [TBL] [Abstract][Full Text] [Related]
19. Accuracy of arrhythmia recognition in paramedic treatment of paroxysmal supraventricular tachycardia: a ten-year review. Goebel PJ; Daya MR; Gunnels MD Prehosp Emerg Care; 2004; 8(2):166-70. PubMed ID: 15060851 [TBL] [Abstract][Full Text] [Related]
20. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]